WisdomTree BioRevolution Fund Rating $14.14 +0.87 (+6.58%) As of 07/3/2025 01:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHeadlinesHoldingsOwnershipRatingsBuy This Stock WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy 2.67Holdings in WDNA have an aggregate rating of Moderate Buy based on 645 analyst ratings issued in the past year covering 46 companies (72.2% of the portfolio).WDNA Aggregate Price Target$14.14High Prediction$14.14Average Prediction$14.14Low Prediction$14.14Holdings in WDNA have an aggregate price target of $14.14 and a range of $14.14 to $14.14 covering 46 companies (72.2% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy26 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 46 WDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.49%VERVVerve Therapeutics$11.23+0.1%3.4247 of 5 stars2.33$14.57 29.8%92.71%NTRANatera$161.500.0%2.1367 of 5 stars3.00$184.63 14.3%15News CoveragePositive NewsInsider Trade2.47%NTLAIntellia Therapeutics$10.72-0.1%4.7198 of 5 stars2.65$33.37 211.4%20News Coverage2.36%CRSPCRISPR Therapeutics$52.16+0.9%3.0147 of 5 stars2.53$71.75 37.6%172.19%LLYEli Lilly and Company$779.60+0.0%4.9885 of 5 stars2.75$1,011.61 29.8%20Trending News2.14%TWSTTwist Bioscience$38.11+1.1%4.4645 of 5 stars2.70$50.40 32.2%10Positive News2.12%DNAGinkgo Bioworks$12.660.0%1.1049 of 5 stars1.67$5.77 -54.4%3Gap Up2.04%AGIOAgios Pharmaceuticals$36.06+2.0%4.0072 of 5 stars2.71$58.60 62.5%7Insider Trade1.89%RGNXREGENXBIO$8.73+1.3%4.5239 of 5 stars2.83$31.63 262.3%6Positive News1.85%GILDGilead Sciences$111.28-0.2%4.8402 of 5 stars2.78$110.55 -0.7%27Positive NewsInsider Trade1.76%SANASana Biotechnology$3.20+9.4%2.7699 of 5 stars3.00$9.17 186.9%7Analyst ForecastGap Up1.74%BNTXBioNTech$109.65+1.3%2.3234 of 5 stars2.83$137.86 25.7%181.74%BEAMBeam Therapeutics$20.02+0.7%2.5203 of 5 stars3.00$48.75 143.5%151.69%VRTXVertex Pharmaceuticals$454.64-0.5%4.7236 of 5 stars2.54$511.62 12.5%28Positive News1.68%VCYTVeracyte$27.51-0.3%3.612 of 5 stars2.70$40.90 48.7%101.67%TXG10x Genomics$13.014.6198 of 5 stars2.43$14.96 15.0%141.63%UTHRUnited Therapeutics$294.57-0.2%4.9954 of 5 stars2.69$386.15 31.1%13Positive News1.60%EDITEditas Medicine$2.59+1.0%4.199 of 5 stars2.31$4.70 81.8%131.60%ARCTArcturus Therapeutics$13.64+0.1%3.7667 of 5 stars3.11$54.00 296.0%9News CoverageAnalyst Forecast1.59%MRNAModerna$30.47+0.6%4.4561 of 5 stars2.04$46.61 53.0%23Options VolumeGap Up1.55%TEMTempus AI$60.65+2.5%2.2723 of 5 stars2.54$63.67 5.0%13Trending News1.53%AMGNAmgen$298.25+0.5%4.5208 of 5 stars2.35$307.82 3.2%23Positive News1.51%CTVACorteva$77.24+0.3%4.2966 of 5 stars2.79$72.08 -6.7%14News CoveragePositive News1.32%GPCRStructure Therapeutics$20.62+0.9%2.925 of 5 stars3.00$76.17 269.4%7Positive News1.31%DARDarling Ingredients$39.45+0.5%3.8345 of 5 stars3.00$46.00 16.6%9Positive News1.30%IONSIonis Pharmaceuticals$42.98-1.4%4.6791 of 5 stars2.78$58.25 35.5%18News CoverageAnalyst Upgrade1.30%AZNAstraZeneca$69.60-2.2%2.3165 of 5 stars2.83$85.00 22.1%6News CoveragePositive News1.23%TECHBio-Techne$53.14-0.1%4.9777 of 5 stars2.45$72.00 35.5%11Positive News1.22%RAREUltragenyx Pharmaceutical$39.19-0.7%4.0717 of 5 stars2.93$87.00 122.0%141.20%STOKStoke Therapeutics$11.49-0.6%3.9341 of 5 stars3.29$23.20 102.0%7News CoverageAnalyst Forecast1.19%BMRNBioMarin Pharmaceutical$57.25+0.1%4.9439 of 5 stars2.75$93.61 63.5%24Analyst Forecast1.16%JNJJohnson & Johnson$155.90+0.2%4.8465 of 5 stars2.55$170.88 9.6%20Positive News1.14%DHRDanaher$203.08+0.3%4.8617 of 5 stars2.80$248.61 22.4%20News CoveragePositive News1.13%QUREuniQure$14.49+1.4%1.9636 of 5 stars2.91$37.82 161.1%11News Coverage1.13%BMYBristol Myers Squibb$47.02-1.3%4.9455 of 5 stars2.32$58.00 23.4%22Positive News1.10%ZTSZoetis$159.19+0.1%4.838 of 5 stars3.00$212.13 33.3%10News CoveragePositive News1.06%FOLDAmicus Therapeutics$6.16+3.4%3.707 of 5 stars2.70$16.22 163.6%101.04%ABSIAbsci$2.76+2.4%2.0797 of 5 stars3.00$8.40 204.9%5News CoverageAnalyst ForecastGap Up1.04%EXASExact Sciences$52.82-1.9%4.9409 of 5 stars2.95$70.40 33.3%22News CoveragePositive NewsAnalyst Revision1.03%GERNGeron$1.43+1.8%2.71 of 5 stars2.78$5.06 255.3%91.03%GMABGenmab A/S$20.41-0.1%3.5865 of 5 stars2.67$37.60 84.2%120.98%PFEPfizer$25.45+0.5%4.9793 of 5 stars2.45$28.55 12.2%22Trending News0.97%RGENRepligen$127.36+0.3%4.7718 of 5 stars2.69$172.83 35.7%13News Coverage0.96%IMNMImmunome$8.71+0.9%2.4535 of 5 stars3.00$23.33 167.9%60.94%SWTXSpringWorks Therapeutics$46.991.37 of 5 stars2.13$52.57 11.9%80.90%REGNRegeneron Pharmaceuticals$545.00-0.5%4.957 of 5 stars2.80$813.57 49.3%25 This page (BATS:WDNA) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share WisdomTree BioRevolution Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WDNA Stock Alerts